Foyston, Gordon, & Payne Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$7.3M |
| 2 |
Electronic Arts
EA
|
+$3.86M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.94M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.86M |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allison Transmission
ALSN
|
+$5.45M |
| 2 |
Cisco
CSCO
|
+$2.48M |
| 3 |
Expedia Group
EXPE
|
+$1.84M |
| 4 |
RTX Corp
RTX
|
+$1.72M |
| 5 |
Motorola Solutions
MSI
|
+$1.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.9% |
| 2 | Healthcare | 16.11% |
| 3 | Financials | 15.02% |
| 4 | Consumer Staples | 13.33% |
| 5 | Communication Services | 10.7% |
Similar funds
Foyston, Gordon, & Payne's Q1 2025 Portfolio in Review
As of Q1 2025, Foyston, Gordon, & Payne held 60 positions worth $404M, up 7.1% from $378M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Foyston, Gordon, & Payne deployed $32.1M of net new capital in Q1 2025, opening 8 new positions and adding to 32 existing holdings. Its largest new stake was Electronic Arts: 28,618 shares worth $4.14M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Allison Transmission, an estimated $5.45M trimmed.
- Foyston, Gordon, & Payne's largest Q1 2025 buy was Electronic Arts: 28,618 shares worth $4.14M.
- Foyston, Gordon, & Payne added most to UnitedHealth in Q1 2025, an estimated $7.3M increase.
- Foyston, Gordon, & Payne's biggest Q1 2025 reduction was Allison Transmission, cutting an estimated $5.45M.
- Foyston, Gordon, & Payne fully exited Cisco in Q1 2025, selling an estimated $2.48M.
- Foyston, Gordon, & Payne's ten largest holdings make up 51% of its $404M portfolio in Q1 2025.
- Foyston, Gordon, & Payne opened 8 new positions and closed 3 in Q1 2025.
- Foyston, Gordon, & Payne's portfolio value rose 7.1% quarter-over-quarter to $404M.
Based on Foyston, Gordon, & Payne's 13F filing for Q1 2025, filed 13 May 2025.